Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder

Receipt of methadone was associated with a lower risk of treatment discontinuation compared with buprenorphine/naloxone. The risk of mortality while receiving treatment was similar for buprenorphine/naloxone and methadone, although the CI estimate for the hazard ratio was wide.

Authors

Institutions

Publication Details

Journal
JAMA
Published
2024-10-17
DOI
https://doi.org/10.1001/jama.2024.16954
Citations
44
Primary Topic
Opioid Use Disorder Treatment
Type
article
Field-Weighted Citation Impact
23.89
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder

Micah Piske, Paxton Bach, Uwe Siebert, Brenda Carolina Guerra‐Alejos et al.
44 citations
JAMA
Opioid Use Disorder Treatment
23.89
article

Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder

Micah Piske, Paxton Bach, Uwe Siebert, Brenda Carolina Guerra‐Alejos, Kyle M. Kampman, Jeong Eun Min, P. Todd Korthuis, M. Eugenia Socías, Mohammad Ehsanul Karim, Paul Gustafson, Shaun R. Seaman, Julie Bruneau, Bohdan Nosyk, Kevin Schnepel, Robert W. Platt, Lawrence C. McCandless, Megan Kurz, Fahmida Homayra, Ruyu Yan, Sander Greenland, Thomas M. Loughin
article en
44 citations

Abstract

Receipt of methadone was associated with a lower risk of treatment discontinuation compared with buprenorphine/naloxone. The risk of mortality while receiving treatment was similar for buprenorphine/naloxone and methadone, although the CI estimate for the hazard ratio was wide.

JAMAVol. 332(21)
Portland State University (US), Harvard University (US), University of British Columbia (CA), Oregon Health & Science University (US), Simon Fraser University (CA), University of Cambridge (GB), Massachusetts General Hospital (US), British Columbia Centre on Substance Use (CA), UMIT - Private Universität für Gesundheitswissenschaften, Medizinische Informatik und Technik (AT), MRC Biostatistics Unit (GB), Centre for Advancing Health Outcomes (CA), Centre Hospitalier de l’Université de Montréal (CA), McGill University (CA), Université de Montréal (CA), University of Pennsylvania (US), Medical Research Council (GB)
Good health and well-being
Openalex Percentile: Top 0%
Opioid Use Disorder Treatment
23.89
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.